News & Media

Coverage of the Gray Foundation’s latest “Team Science” awards mentions the Grays’ role in establishing the Basser Center for BRCA in 2012.

Gregory Bowman, PhD hopes to uncover how to drug proteins related to the BRCA1 and BRCA2 genes which, when mutated, can lead to breast, ovarian, prostate, and pancreatic cancers.

Let's Win recaps our 2023 Breakthroughs & Discoveries Panel from the 11th Annual Basser Center Scientific Symposium. The broad-ranging discussion among experts in the field focused on screening, treatment and preventing BRCA-related cancers.

The golf event brought together elite athletes and entertainers, raising nearly $700,000 to support the Pennsylvania Breast Cancer Coalition and Penn Medicine’s Basser Center.

Susan M. Domchek, MD, executive director of the Basser Center, joined “Tonight with Andrew Marr” to discuss recent progress in the field of cancer vaccine research.

Basser Center presented the inaugural BRCA Impact Award to Mary B. Daly, MD, PhD, FACP, of Fox Chase Cancer Center. The award recognizes a national leader in the field of cancer genetics.

Katherine Nathanson, MD, Director of Genetics at the Basser Center, on her new research endeavor: “Expanding The Spectrum of BRCA1/2 Pathogenic Variants” funded by BRCA Research and Cure Alliance.

Scientists say research has reached a turning point, predicting more vaccines will be out in five years. Susan Domchek, MD, Basser executive director, and her work in recruiting healthy people with BRCA mutations for the vaccine test are mentioned.

Katherine Nathanson, MD, the Pearl Basser Professor for BRCA-Related Research, commented on a large study about genetic sequencing for hereditary cancer syndromes presented at the AACR Annual Meeting in April 2023.

The Deseret News covered efforts to create a vaccine for breast cancer. Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, and Susan M. Domchek, MD, executive director of the Basser Center, were quoted.